Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(S)-1-((3S,6S,9S,15S,18S)-1-((3R,8S,11S,14S,17S,20S,23R,26S,29R,34R,40S,43S,46R,49S,52S,55S,60aS,70S,73S,76S,79S,82S)-34-amino-17-(2-amino-2-oxoethyl)-14,20-bis(4-aminobutyl)-52,82-dibenzyl-55,70-di((S)-sec-butyl)-40-(2-carboxyethyl)-26,43,76,79-tetrakis(hydroxymethyl)-11,49,73-triisopropyl-1,10,13,16,19,22,25,28,35,38,41,44,47,50,53,56,66,69,72,75,78,81,84-tricosaoxohexapentacontahydro-29,3-(epiminoethanoiminoethanoiminoethanoiminoethanoiminoethanoiminoethanoiminomethano)-23,46-(methanodithiomethano)pyrrolo[2,1-g][1,2,33,34,5,8,11,14,17,20,23,26,29,38,41,44,47,50,53,56]tetrathiahexadecaazacyclooctapentacontin-8-yl)-9-(2-amino-2-oxoethyl)-18-((S)-sec-butyl)-6-(3-guanidinopropyl)-3-(4-hydroxybenzyl)-15-isopropyl-1,4,7,10,13,16-hexaoxo-2,5,8,11,14,17-hexaazanonadecan-19-oyl)pyrrolidine-2-carboxylic acid
ID: ALA4871862
PubChem CID: 164622968
Max Phase: Preclinical
Molecular Formula: C142H220N38O41S6
Molecular Weight: 3307.95
Molecule Type: Unknown
Associated Items: